Year: 2018
Type: editorial
Abstract: Esophageal cancer (EC) is the eleventh most common cause of cancer worldwide (459,299 cases) and the sixth most common cause of cancer mortality (439,000 deaths) (1). Esophageal squamous cell carcinoma (ESCC) is one of the major histological types, whose incidence has been decreasing in West, but remains the most common type in Asia, Africa, and South America. Prognosis of metastatic ESCC is poor even though it initially sensitive to combination chemotherapy, but resistance emerges rapidly. There has not been an effective targeted agent to treat ESCC.
Source: Journal of Thoracic Disease
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Awards: G1655421535, G1677944058, Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha, Molecular Markers of Response to Chemoradiation in Localized Esophageal Cancer, G451806386, G5208572710, G5313212532, G6077205801, G7623734931, G7659053506, Molecular Biomarkers as Classifiers to Individualize Therapy of Esophagus Cancer, Inhibition of Hedgehog Signaling in Gli-1+Adeno CA of the Esoph or GE junction, G8705956310
OpenAlex ID: W2785612832